Testing effectiveness (Phase 2)Study completedNCT04764968
What this trial is testing
Pen-Administered Low-Dose Dasiglucagon for Prevention and Treatment of Hypoglycemia in People With Type 1 Diabetes
Who this might be right for
Type 1 DiabetesHypoglycemia
Steno Diabetes Center Copenhagen 24